Key result
The Neuropad sudomotor test demonstrated moderate diagnostic accuracy for diabetic cardiovascular autonomic neuropathy (AUC 0.71) and diabetic polyneuropathy (AUC 0.76).
Why the study?
Does the Neuropad sudomotor test accurately diagnose cardiovascular autonomic neuropathy and diabetic polyneuropathy in diabetic patients?
Cross-Sectional (n=51)
Does the Neuropad sudomotor test accurately diagnose cardiovascular autonomic neuropathy and diabetic polyneuropathy in diabetic patients?
Effect estimate: AUC 0.71 for CAN, 0.76 for DPN
The Neuropad sudomotor test offers a reliable, moderately accurate diagnostic tool for diabetic cardiovascular autonomic and polyneuropathy, optimized by a 15-minute observation period.
No takes yet. Share an insight, caveat, or question.
Should not yet change neuropathy screening in diabetes; leaves open prospective validation of Neuropad.
Spallone et al. (2009) conducted a cross-sectional in diabetic cardiovascular autonomic neuropathy and diabetic polyneuropathy (n=51). Neuropad sudomotor test was evaluated on diagnostic accuracy (area under the ROC curve) for CAN and DPN (AUC 0.71 for CAN, 0.76 for DPN). The Neuropad sudomotor test demonstrated moderate diagnostic accuracy for diabetic cardiovascular autonomic neuropathy (AUC 0.71) and diabetic polyneuropathy (AUC 0.76).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: